ACME Laboratories (DHA:ACMELAB) EV-to-EBITDA : 8.12 (As of May. 25, 2024)

ACME Laboratories EV-to-EBITDA Chart

ACME Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
EV-to-EBITDA	Get a 7-Day Free Trial															7.25	7.70	8.17	7.36	8.40

Competitive Comparison of ACME Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ACME Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's EV-to-EBITDA falls into.

ACME Laboratories EV-to-EBITDA Calculation

ACME Laboratories's EV-to-EBITDA for today is calculated as:

ACME Laboratories's current Enterprise Value is BDT35,476 Mil.
ACME Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT4,369 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACME Laboratories  (DHA:ACMELAB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ACME Laboratories's PE Ratio for today is calculated as:

ACME Laboratories's share price for today is BDT66.60.
ACME Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT8.765.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

ACME Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories (DHA:ACMELAB) Business Description